Ling-Ying Lu
Overview
Explore the profile of Ling-Ying Lu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
85
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yen L, Yen C, Li C, Liao E, Wang K, Shih M, et al.
J Pers Med
. 2025 Feb;
15(2).
PMID: 39973627
The journal retracts the article "Brevilin A Ameliorates Imiquimod-Induced Psoriasis-like Dermatitis and Reduces Th17 Differentiation in Psoriasis Patients" [...].
2.
Tseng H, Lu L
Asian Pac J Allergy Immunol
. 2024 Apr;
PMID: 38642326
Background: Air volatile organic compounds (VOCs) cause allergic reaction mainly via the respiratory tract or skin. Objective: This study aimed to investigate the association between daily visits by patients with...
3.
Wang K, Sun Y, Tsai H, Liao H, Lai C, Chen W, et al.
Mod Rheumatol
. 2024 Feb;
34(5):1027-1035.
PMID: 38302085
Objectives: To assess the link between the administration of biologic disease-modifying antirheumatic drugs (bDMARDs) and the risk of malignancy in human leukocyte antigen B27 (HLA-B27)-positive patients with ankylosing spondylitis (AS)...
4.
Yen L, Chen Y, Wang K, Shih M, Li C, Yu S, et al.
Immunopharmacol Immunotoxicol
. 2023 Dec;
46(1):128-137.
PMID: 38059657
Objective: Hydroxychloroquine (HCQ) is a US Food and Drug Administration (FDA)-approved treatment for systemic lupus erythematosus (SLE) through inhibition of antigen presentation and subsequent reduction in T cell activation. Psoriasis...
5.
Hsieh T, Chen M, Wu C, Hong W, Lu C, Lu C, et al.
Int J Rheum Dis
. 2023 Oct;
26(12):2441-2449.
PMID: 37784228
Objectives: This study aimed to investigate the clinical outcomes of granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) under rituximab induction and reinduction therapy in Taiwan. Methods: We performed a...
6.
Shih M, Li C, Liao E, Yen C, Yen L, Wang K, et al.
Int J Mol Sci
. 2023 Sep;
24(17).
PMID: 37686332
Psoriasis is a chronic autoimmune skin disease with a significant impact on quality of life and potential for severe comorbidities. Inflammation in the skin is induced by immune cells that...
7.
Yen L, Yen C, Li C, Liao E, Wang K, Shih M, et al.
J Pers Med
. 2022 Dec;
12(11).
PMID: 36579613
Psoriasis is a predominantly Th17 cell-driven chronic autoinflammatory skin disorder. Brevilin A, a natural sesquiterpene lactone extracted from , has been used as a traditional oriental medicine for allergic diseases...
8.
Lu L, Feng P, Yu M, Chen M, Lin A, Chen J, et al.
Cytokine Growth Factor Rev
. 2022 Feb;
63:34-43.
PMID: 35115233
Recent studies have identified an association between perturbed type I interferon (IFN) responses and the severity of coronavirus disease 2019 (COVID-19). IFNα intervention may normalize the dysregulated innate immunity of...
9.
Lin H, Li C, Yen L, Lu L, Huang H, Liao E, et al.
J Pers Med
. 2022 Jan;
12(1).
PMID: 35055377
Psoriasis is a recurrent inflammatory skin disease characterized by redness and scaly skin lesions with itchy or painful sensations. Forsythoside A, one of the main active compounds isolated from the...
10.
Liou I, Lu L, Lin K, Yu L, Yang S, Tsai M, et al.
Haemophilia
. 2020 Oct;
27(2):e291-e294.
PMID: 33094883
No abstract available.